Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase 3 study of daclatasvir and asunaprevir in treatment-naive patients with hepatitis C is now available, with study design, participant criteria, locations, and outcome measures. The record indicates the study is completed and is no longer recruiting.
    Difference
    54%
    Check dated 2026-11-09T14:44:37.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T16:29:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says some content may use “Super Intelligence” instead of “Artificial Intelligence.” The page content below remains a 403 error.
    Difference
    1%
    Check dated 2026-10-26T16:22:00.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T21:43:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:19:32.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating an access restriction or server issue. The visible screen displays the standard 403 notice and site chrome rather than the ClinicalTrials.gov study details.
    Difference
    17%
    Check dated 2026-09-21T22:10:17.000Z thumbnail image

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.